Charles River Laboratories International (CRL) Stock Forecast for 2024–2028. Sell or Buy Prediction







Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …

Charles River Laboratories International (CRL) Stock Forecast for 2024–2028. Sell or Buy?

Updated: March 18, 2024 (10:34)

Sector: Healthcare

The share price of Charles River Laboratories International, Inc. (CRL) now

Latest session on the 18th of April for
Charles River Laboratories International, Inc. is negative
Trading Volume: 710218
Open: 228.02 /  High: 233.72 /  Low: 223.49
What analysts predict: $270.8
52-week High/Low: $275 / $161.65

50/200 Day Moving Average: $251.67 / $215.55

This figure corresponds to the Average Price over the previous 50/200 days. For Charles River Laboratories International stocks, the 50-day moving average is the resistance level today.

For Charles River Laboratories International stocks, the 200-day moving average is the support level today.

Are you interested in Charles River Laboratories International, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Charles River Laboratories International stock price in 2024, 2025, 2026, 2027, 2028. How much will one Charles River Laboratories International share be worth in 2024 - 2028?

When should I take profit in Charles River Laboratories International stock? When should I record a loss on Charles River Laboratories International stock? What are analysts' forecasts for Charles River Laboratories International stock? What is the future of Charles River Laboratories International stock? We forecast Charles River Laboratories International stock performance using neural networks based on historical data on Charles River Laboratories International stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Charles River Laboratories International stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Charles River Laboratories International shares. This happens once a day.


Historical and forecast chart of Charles River Laboratories International stock

The chart below shows the historical price of Charles River Laboratories International stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Charles River Laboratories International stock price can be found in the table below.

Long-term forecasts by years.

Charles River Laboratories International, Inc., an early stage contract research company, provides drug discovery, non-clinical development and safety testing services in the United States, Europe, Canada, Asia Pacific and worldwide. It operates across three segments: Research Models and Services (RMS), Security Discovery and Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment manufactures and markets lines of research models and specially bred rats and mice for use by researchers.

Charles River Laboratories International daily forecast for a month

Date Target Pes. Opt. Vol., %
Jan 12 217.77 215.82 219.96 1.92
Jan 13 218.43 217.66 219.16 0.69
Jan 14 218.53 217.35 219.62 1.05
Jan 15 218.99 216.47 220.57 1.89
Jan 16 218.50 216.86 219.34 1.14
Jan 17 219.83 218.81 221.06 1.03
Jan 18 219.86 217.72 220.78 1.41
Jan 19 220.81 220.11 222.68 1.17
Jan 20 217.91 215.37 219.27 1.81
Jan 21 216.07 214.72 217.24 1.18
Jan 22 214.48 212.35 215.71 1.58
Jan 23 214.10 213.00 215.26 1.06
Jan 24 215.26 213.58 217.23 1.71
Jan 25 214.54 213.58 217.29 1.74
Jan 26 215.67 212.98 216.78 1.78
Jan 27 214.60 213.26 216.60 1.56
Jan 28 213.92 212.27 215.18 1.37
Jan 29 214.91 214.02 216.63 1.22
Jan 30 212.12 209.85 213.58 1.78
Jan 31 209.17 207.00 211.38 2.12
Feb 01 209.61 208.40 210.48 1.00
Feb 02 206.55 205.33 208.57 1.58
Feb 03 206.65 205.79 209.27 1.69
Feb 04 205.00 202.38 206.84 2.20
Feb 05 208.12 206.85 210.38 1.71
Feb 06 207.05 205.16 208.18 1.47
Feb 07 204.93 204.11 206.50 1.17
Feb 08 203.59 202.28 205.25 1.47
Feb 09 204.86 202.73 205.94 1.58
Feb 10 206.23 205.41 208.74 1.62

Charles River Laboratories International Daily Price Targets


Charles River Laboratories International Stock Forecast 01-12-2024.

Forecast target price for 01-12-2024: $217.77.
Negative dynamics for Charles River Laboratories International shares will prevail with possible volatility of 1.885%.
Pessimistic target level: 215.82
Optimistic target level: 219.96

Charles River Laboratories International Stock Forecast 01-13-2024.

Forecast target price for 01-13-2024: $218.43.
Positive dynamics for Charles River Laboratories International shares will prevail with possible volatility of 0.686%.
Pessimistic target level: 217.66
Optimistic target level: 219.16

Charles River Laboratories International Stock Forecast 01-14-2024.

Forecast target price for 01-14-2024: $218.53.
Positive dynamics for Charles River Laboratories International shares will prevail with possible volatility of 1.035%.
Pessimistic target level: 217.35
Optimistic target level: 219.62

Charles River Laboratories International Stock Forecast 01-15-2024.

Forecast target price for 01-15-2024: $218.99.
Positive dynamics for Charles River Laboratories International shares will prevail with possible volatility of 1.858%.
Pessimistic target level: 216.47
Optimistic target level: 220.57

Charles River Laboratories International Stock Forecast 01-16-2024.

Forecast target price for 01-16-2024: $218.50.
Negative dynamics for Charles River Laboratories International shares will prevail with possible volatility of 1.132%.
Pessimistic target level: 216.86
Optimistic target level: 219.34

Charles River Laboratories International Stock Forecast 01-17-2024.

Forecast target price for 01-17-2024: $219.83.
Positive dynamics for Charles River Laboratories International shares will prevail with possible volatility of 1.018%.
Pessimistic target level: 218.81
Optimistic target level: 221.06

CRL (CRL) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
May. 247.30 240.55 256.65 6.27
Jun. 247.30 240.21 260.29 7.71
Jul. 238.99 232.30 246.52 5.77
Aug. 227.95 215.98 232.10 6.94
Sep. 223.01 212.55 229.72 7.48
Oct. 235.03 223.02 239.96 7.06
Nov. 246.05 236.40 259.83 9.02
Dec. 253.63 250.08 264.99 5.63

Charles River Laboratories International forecast for this year


Charles River Laboratories International Stock Prediction for May 2024

An uptrend is forecast for this month with an optimal target price of $247.303. Pessimistic: $240.55. Optimistic: $256.65


Charles River Laboratories International Stock Prediction for Jun 2024

An downtrend is forecast for this month with an optimal target price of $247.303. Pessimistic: $240.21. Optimistic: $260.29


Charles River Laboratories International Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $238.993. Pessimistic: $232.30. Optimistic: $246.52


Charles River Laboratories International Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $227.952. Pessimistic: $215.98. Optimistic: $232.10


Charles River Laboratories International Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $223.005. Pessimistic: $212.55. Optimistic: $229.72


Charles River Laboratories International Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $235.025. Pessimistic: $223.02. Optimistic: $239.96


Charles River Laboratories International Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $246.048. Pessimistic: $236.40. Optimistic: $259.83


Charles River Laboratories International Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $253.626. Pessimistic: $250.08. Optimistic: $264.99



Charles River Laboratories International (CRL) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 257.18 242.78 265.82 8.67
Feb 256.10 249.11 260.94 4.53
Mar 264.88 257.28 269.70 4.61
Apr 250.05 241.82 256.52 5.73
May 248.12 243.43 253.33 3.91
Jun 264.80 254.23 279.63 9.08
Jul 257.01 249.64 262.95 5.06
Aug 267.63 259.38 273.62 5.20
Sep 259.20 252.48 264.64 4.59
Oct 256.47 248.57 269.22 7.67
Nov 265.63 251.87 276.42 8.88
Dec 259.31 250.23 270.56 7.51

Charles River Laboratories International (CRL) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 242.79 238.54 247.89 3.77
Feb 234.80 228.23 241.87 5.64
Mar 239.73 235.03 243.43 3.45
Apr 236.88 228.09 242.52 5.95
May 248.49 241.88 259.27 6.71
Jun 253.01 242.03 257.08 5.86
Jul 260.09 251.54 267.56 5.99
Aug 257.55 244.39 264.58 7.63
Sep 255.92 246.25 261.30 5.76
Oct 253.42 241.35 266.36 9.39
Nov 250.75 246.72 256.02 3.63
Dec 247.07 233.23 259.69 10.19

Charles River Laboratories International (CRL) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 253.12 240.19 259.50 7.44
Feb 249.22 237.36 254.98 6.91
Mar 241.55 229.88 249.66 7.92
Apr 239.35 228.29 252.08 9.44
May 232.81 229.39 242.43 5.38
Jun 224.67 212.40 236.46 10.18
Jul 234.89 225.52 246.40 8.47
Aug 231.27 223.34 239.37 6.70
Sep 233.21 221.30 245.13 9.72
Oct 232.07 219.08 244.74 10.49
Nov 232.56 220.84 242.16 8.81
Dec 229.95 219.17 240.10 8.72

Charles River Laboratories International (CRL) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 236.23 226.31 240.20 5.78
Feb 236.07 229.29 245.16 6.47
Mar 245.32 235.70 253.05 6.85
Apr 260.95 248.89 269.53 7.66
May 273.55 259.00 284.66 9.01
Jun 270.87 266.89 285.28 6.45
Jul 275.42 264.24 281.20 6.03
Aug 282.94 278.38 294.43 5.45
Sep 280.76 273.88 288.23 4.98
Oct 262.48 253.66 274.79 7.69
Nov 270.02 264.91 284.19 6.78
Dec 270.02 264.72 275.69 3.98

Charles River Laboratories International information and performance

Charles River Laboratories International Address

251 BALLARDVALE ST, WILMINGTON, MA, US

Market Capitalization: 11 968 019 000 $

Market capitalization of the Charles River Laboratories International, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CRL shares in the company outstanding by the market price of one share.

EBITDA: 970 294 000 $

EBITDA of Charles River Laboratories International is earnings before interest, income tax and depreciation of assets.

PE Ratio: 25.2

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 1.87

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 9.22

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.006
Quarterly Revenue Growth YOY: -0.079
Trailing PE: 25.2

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 22.03

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.686

Enterprise Value (EV) /Revenue

EV To EBITDA: 14.75

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 51511000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.